Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy
Nano Letters · 24.07.2024 · 24 (29) · 9017-9026
DOI: 10.1021/acs.nanolett.4c02113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 15.07.2024. Verfasst von Shuaiqi Shao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, Peo…. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Nanoparticles, Adjuvants, Immunologic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Scientific and Technological Planning Project of Guangzhou City.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, People's Republic of China.
- Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, Guangzhou First People's Hospital, the Second Affiliated Hospital, South China University of Technology, Guangzhou, Guangdong 51…
- School of Medicine, South China University of Technology, Guangzhou 510006, People's Republic of China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, and Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, Guangdong 510006, People'…
ORCID-Profile: Zekai Xiao, Xianzhu Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Scientific and Technological Planning Project of Guangzhou City
Zitieren
APA
Shao, S., Cao, Z., Xiao, Z., Yu, B., Hu, L., Du, X. J., & Yang, X. (2024). Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy. Nano Letters, 24(29), 9017-9026. https://doi.org/10.1021/acs.nanolett.4c02113
Vancouver
Shao S, Cao Z, Xiao Z, Yu B, Hu L, Du XJ, et al. Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy. Nano Letters. 2024;24(29):9017-9026. doi:10.1021/acs.nanolett.4c02113
BibTeX
@article{Shao2024,
author = {Shao, Shuaiqi and Cao, Ziyang and Xiao, Zekai and Yu, Boya and Hu, Lingwei and Du, Xiao-Jiao and Yang, Xianzhu},
title = {Programming of in Situ Tumor Vaccines via Supramolecular Nanodrug/Hydrogel Composite and Deformable Nanoadjuvant for Cancer Immunotherapy},
journal = {Nano Letters},
year = {2024},
volume = {24},
number = {29},
pages = {9017--9026},
doi = {10.1021/acs.nanolett.4c02113}
}
EUVIMED